[Drug treatment of bleeding esophageal varices. Acute therapy and prevention of recurrence].
Maier
K P
KP
D000208:Acute Disease; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000818:Animals; D004359:Drug Therapy, Combination; D004932:Esophageal and Gastric Varices / Q000150:complications* / Q000401:mortality; D006471:Gastrointestinal Hemorrhage / Q000188:drug therapy* / Q000209:etiology / Q000401:mortality; D006801:Humans; D006975:Hypertension, Portal / Q000188:drug therapy; D008236:Lypressin / Q000031:analogs & derivatives / Q000627:therapeutic use; D005996:Nitroglycerin / Q000008:administration & dosage; D009599:Nitroprusside / Q000008:administration & dosage; D012008:Recurrence; D012306:Risk; D013004:Somatostatin / Q000627:therapeutic use; D000077585:Terlipressin; D014667:Vasopressins / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D014667:Vasopressins; D009599:Nitroprusside; D008236:Lypressin; D013004:Somatostatin; D000077585:Terlipressin; D005996:Nitroglycerin
Die medikamentöse Behandlung der Osophagusvarizenblutung. Akuttherapie und Rezidivprophylaxe.